LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Company News/SITES Medical and Mach Medical Open New Headquarters
Company News

SITES Medical and Mach Medical Open New Headquarters

February 11, 2021 2 min read Premium comments

Advertisement

SITES Medical and Mach Medical Open New Headquarters
SITES Medical and Mach Medical New Headquarter / Courtesy of SITES Medical and Mach Medical
Secondary#machmedical#sitesmedical

SITES Medical and its sister company Mach Medical have announced the official opening of their new headquarters facility in Columbia City, Indiana. According to the companies, the facility is equipped with high velocity, single piece flow manufacturing capability which can help orthopedic OEMs (original equipment manufacturers) reduce their inventory by up to 83% and cost of goods by as much as 48%.

“We are thrilled to be operating in our new facility”, said Steve Rozow, co-founder and general manager of Mach Medical. “A custom-designed building with an open floorplan gives us the flexibility to configure equipment and working groups as needed over time.”

Greg Stalcup, CEO and founder of SITES Medical and co-founder of Mach Medical, added, “Our new facility gives us the space we need to continue to grow and deliver on our mission. We are grateful to a host of partners who have helped us realize this key milestone in our evolution, including Weigand Construction, Design Collaborative, the Indiana Economic Development Corporation (IEDC) and Whitley County EDC.”

Compressed lead times, less inventory…

As Steve Rozow explained to OTW, these investments will benefit orthopedic OEMs in several ways, most of which increase the speed and quality of component fabrication. “High velocity single-piece flow manufacturing helps orthopedic OEMs reduce their inventory by making and delivering only the component sizes needed for a given patient in time for their surgery.”

“With high velocity manufacturing, lead times as short as three weeks are accommodated. This approach enables orthopedic OEMs to vastly reduce their inventory from the estimated 12 months on hand that they typically carry down to two or three months. That said, we also understand that some OEMs aren’t quite ready to migrate to this approach, so we also offer highly efficient batch process manufacturing.”

…with higher performance, tighter tolerance, more affordable components

“There are several technologies that contribute to the high velocity single-piece flow capability developed by Mach Medical and sister company, SITES Medical. The first is OsteoSync Ti, a high performance, lower cost porous ingrowth material that is applied early in the manufacturing process and is robust enough to withstand automated handling and the uniform and open pore structure makes it easy to clean.”

“The second is a dimensional stabilization process that greatly reduces the potential for dimensional movement of the part outside the tolerance band during manufacturing, enabling consistent process flow with no time-consuming and costly off-line rework and inspection required. Additional technology enablers include zero-setup processes, common fixturing, automated transfer systems, digital online inspection and other state-of-the-art manufacturing techniques.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy